8-132079889-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001145095.3(HHLA1):c.754G>A(p.Gly252Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000271 in 1,552,008 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001145095.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HHLA1 | NM_001145095.3 | c.754G>A | p.Gly252Arg | missense_variant | 11/17 | ENST00000414222.2 | NP_001138567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HHLA1 | ENST00000414222.2 | c.754G>A | p.Gly252Arg | missense_variant | 11/17 | 5 | NM_001145095.3 | ENSP00000388322.1 | ||
ENSG00000258417 | ENST00000262283.5 | c.152-1918G>A | intron_variant | 5 | ENSP00000262283.5 | |||||
HHLA1 | ENST00000473291.1 | n.1216G>A | non_coding_transcript_exon_variant | 1/7 | 1 | |||||
HHLA1 | ENST00000673615.1 | c.862G>A | p.Gly288Arg | missense_variant | 12/18 | ENSP00000500443.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000505 AC: 8AN: 158272Hom.: 0 AF XY: 0.0000719 AC XY: 6AN XY: 83394
GnomAD4 exome AF: 0.0000279 AC: 39AN: 1399912Hom.: 1 Cov.: 32 AF XY: 0.0000333 AC XY: 23AN XY: 690430
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74304
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at